Founded in Madrid, Spain, Tucuvi builds LOLA, an AI voice agent that conducts autonomous, protocol-driven phone calls with patients on behalf of healthcare providers. LOLA follows evidence-based medical protocols to handle remote patient monitoring, symptom assessment, medication adherence checks, and appointment management, surfacing results to clinicians through integrated dashboards so care teams can act on flagged cases. The platform is used by hospitals, health systems, and pharmaceutical companies across Spain, the UK, and wider Europe, and clinicians report that patients followed up by LOLA arrive better prepared and communicate their progress more accurately. Tucuvi positions its voice AI as a way to scale care management without expanding staffing. In January 2026 the company raised a $20M Series A led by Cathay Innovation and Kfund (via Leadwind), with existing investors Frontline Ventures, Seaya Ventures, and Shilling participating, to accelerate adoption across healthcare organizations and expand in the U.S. from its New York office.